KALM Therapeutics, Inc.
Biotechnology company · Huntsville, Alabama, United States
KALM Therapeutics, Inc. is a biotechnology company headquartered in Huntsville, Alabama, United States. Its earliest recorded incorporation is in 2024. It has reported private securities offerings to the US SEC, most recently $590,380 sold in a notice filed in 2024.
KALM Therapeutics at a glance
What does KALM Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $590,380 sold (2024).
Frequently asked questions about KALM Therapeutics
Where is KALM Therapeutics headquartered?
KALM Therapeutics, Inc. is headquartered in Huntsville, Alabama, United States.
What does KALM Therapeutics do?
KALM Therapeutics, Inc. is a biotechnology company.
When was KALM Therapeutics founded?
The earliest incorporation on record for KALM Therapeutics, Inc. is in 2024, according to public company registers.
Similar companies
- iXpressGenes, Inc.Huntsville, Alabama, United States
- CFD Research CorporationHuntsville, Alabama, United States
- DIATHERIX, Inc.Huntsville, Alabama, United States
- BioHSV Holdings, Inc.Huntsville, Alabama, United States
- Kailos Genetics, Inc.Huntsville, Alabama, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences